Chimerix, Inc. (CMRX): Price and Financial Metrics

CMRX POWR Grades

• Value is the dimension where CMRX ranks best; there it ranks ahead of 79.88% of US stocks.
• CMRX's strongest trending metric is Quality; it's been moving down over the last 179 days.
• CMRX's current lowest rank is in the Stability metric (where it is better than 4.21% of US stocks).

CMRX Stock Summary

• CMRX's current price/earnings ratio is 0.73, which is higher than just 0.73% of US stocks with positive earnings.
• Over the past twelve months, CMRX has reported earnings growth of -274.57%, putting it ahead of merely 6.02% of US stocks in our set.
• Revenue growth over the past 12 months for CHIMERIX INC comes in at 5,998.75%, a number that bests 99.74% of the US stocks we're tracking.
• If you're looking for stocks that are quantitatively similar to CHIMERIX INC, a group of peers worth examining would be OCUP, CAPR, ARCT, MRSN, and ZYME.
• Visit CMRX's SEC page to see the company's official filings. To visit the company's web site, go to www.chimerix.com.

CMRX Valuation Summary

• In comparison to the median Healthcare stock, CMRX's price/sales ratio is 27.45% lower, now standing at 3.7.
• CMRX's price/sales ratio has moved down 9.2 over the prior 123 months.

Below are key valuation metrics over time for CMRX.

CMRX Growth Metrics

The 3 year net income to common stockholders growth rate now stands at -49.37%.
• Its 4 year net cashflow from operations growth rate is now at -43.98%.
• The 3 year price growth rate now stands at -42.16%.

Over the past 49 months, CMRX's revenue has gone up $28,860,000.

The table below shows CMRX's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	33.056	-60.902	153.629
2022-06-30	0.608	-83.318	-106.293
2022-03-31	0.559	-85.481	-100.588
2021-12-31	1.979	-99.93	-173.236
2021-09-30	3.053	-74.952	-145.413
2021-06-30	4.555	-67.963	-138.264

CMRX's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• CMRX has a Quality Grade of C, ranking ahead of 50.17% of graded US stocks.
• CMRX's asset turnover comes in at 0.038 -- ranking 340th of 682 Pharmaceutical Products stocks.
• CDXC, NAII, and PLX are the stocks whose asset turnover ratios are most correlated with CMRX.

The table below shows CMRX's key quality metrics over time.